Skip to main content
Fig. 3 | Tropical Diseases, Travel Medicine and Vaccines

Fig. 3

From: The role of antibody-dependent enhancement in dengue vaccination

Fig. 3

Schematic representation of the dengue virus (A), the tetravalent vaccines Dengvaxia (B) and Qdenga (C) and the vaccine formulation TV003/TV005 (D). The dengue virus has an RNA genome with an open reading frame surrounded by untranslated regions. The open reading frame contains the genetic coding for three structural and seven non-structural (NS) proteins. The three structural proteins (capsid (C), premembrane (prM), and envelope)) form the structural components of the dengue virus particle

Back to article page